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BK virus salivary shedding and 
viremia in renal transplant recipients
Objectives: This study aimed to verify the presence of polyomavirus 
BK (BKPyV) in the saliva of kidney transplant recipients and to correlate 
it with blood viremia. Material and Methods: We have conducted a cross-
sectional study with a sample involving 126 renal transplant recipients. 
126 samples of saliva and 52 samples of blood were collected from these 
patients. Detection and quantification of BKPyV were performed using a 
real-time PCR. To compare the presence of BKPyV in blood and saliva, the 
binomial proportion test was used. To verify associations between salivary 
shedding BKPyV and post-transplant periods (in months), the Mann-Whitney 
test was used. Spearman’s correlation was used to correlate the viral load 
in the saliva with blood of kidney transplant recipients. Results: The mean 
age of the study group was 51.11±12.45 years old, and 69 participants 
(54.8%) were female, with a mean post-transplantation time of 4.80±6.04 
months. BKPyV was quantified in several samples of saliva and blood, with 
medians of 1,108 cp/mL and 1,255 cp/mL, respectively. Only 16/52 (30.8%) 
participants presented BKPyV in blood, and 59/126 (46.8%) excreted the 
virus in saliva (p=0.004). BKPyV shedding was found in patients at a shorter 
post-transplantation period (3.86±5.25, p=0.100). A weak correlation 
was observed between viral quantification in saliva and blood (Spearman’s 
correlation coefficient=0.193). Conclusion: The results of this study suggested 
that, although saliva excretes more BKPyV than blood, there is no reliable 
correlation between salivary shedding and blood viremia, showing two 
independent compartments of viral replication.
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Introduction
Currently, blood biochemical laboratory tests are 
the first choice for patient follow-up and for monitoring 
diseases. However, saliva has been suggested as an 
excellent material for diagnosis and monitoring, mainly 
because the collection of saliva is simple, painless, 
cheap and safe both for patients and the medical 
staff. In addition, saliva is a source of material that 
can be collected several times a day, without harming 
the patient1.
Polyomavirus BK (BKPyV) has a high prevalence of 
asymptomatic infection in the normal population and is 
able to cause kidney dysfunction in transplanted grafts 
via BK virus-associated nephritis, mainly because 
these patients are immunocompromised. Screening 
for BKPyV often reveals viruria and/or viremia, which 
can progress to active diseases2-4.
Kidney transplant recipients need special care 
and attention in the transplantation follow-up. 
Immunosuppression treatment is essential for 
the maintenance of kidney transplantation, but it 
negatively influences the balance between viral 
replication and cellular immune response. This leads 
to a potential risk of primary infections or opportunistic 
reactivations4,5. BKPyV causes 95% of nephropathy 
cases related to polyomavirus, with the remaining 5% 
being caused by JC virus. Nephropathy impairs graft 
function, causing its premature failure in 1% to 10% 
of the patients with kidney transplants6.
Since BKPyV remains latent in renal tissue, kidney 
transplant recipients are monitored with great interest 
for detection of viruses in order to prevent overt 
clinical disease. Early diagnosis and immunological 
recovery are essential to prevent transplant rejection 
in these patients. Non-invasive screening can facilitate 
the detection of new cases and monitor previously 
known cases2,6-8. Thus, it is important to know the 
profile of BKPyV oral shedding in these patients and 
to understand the clinical importance of this excretion 
in saliva for them. The objective of this research was 
to verify the presence of BKPyV in the saliva of kidney 
transplant recipients and to correlate it with blood 
viremia.
Material and methods
Design and study population
A cross-sectional study was conducted in which 
the subjects were part of a convenience sample of the 
Kidney Transplant Unit of the University of São Paulo, 
São Paulo/SP, Brazil. This study was approved by the 
local Research Ethics Committee according to protocol 
number 0234/10 with all the participants signing an 
informed consent form.
Demographic data were collected, including 
information on gender, age and post-transplant period 
at the time of data collection. The inclusion criteria 
were being over 18 years old, having had kidney 
transplant only regardless of the post-transplantation 
time, whereas the exclusion criteria were using 
antiviral drugs in the past three months before sample 
collection, being HIV-positive or having undergone 
multi-visceral transplant.
Study population involved 126 kidney transplant 
recipients. 126 samples of saliva were collected, and, 
from these same patients, 52 blood samples were also 
collected (only from those who consented to blood 
collection). All samples were collected at the same 
appointment, randomly. Approximately 3 mL of non-
stimulated saliva were collected into a 50 mL Falcon 
tube by using drainage method, with the first-minute 
collection being discarded. Five milliliters of blood were 
collected and put into a tube containing coagulation 
factor, and aliquots of blood sample were separated 
to analyze BKPyV. All samples were stored at -80°C.
DNA extraction and quantification by using 
quantitative real-time PCR
Detection and quantification of BKPyV were 
performed by using a real-time PCR, and laboratory 
procedures were conducted at the Laboratory of 
Virology of the University of São Paulo Institute 
of Tropical Medicine (IMT-USP) 2,3. DNA extraction 
was performed using the QIAamp DNA extraction 
QIAGEN kit, according to protocol for RT-qPCR 
in which primers and specific probes are used to 
detect the gene encoding the Ag-T protein of the 
BKPyV, resulting in a 80-pb fragment (Forward: 
5-GAAACTGAAGACTCTGGACATGGA-3; Reverse: 
5-GGCTGAAGTATCTGAGACTTGGG-3; BKPyV probe: 
CAAGCACTGAATCCCAATCACAATGCTC) 9.
The reaction probes were labeled with FAM 
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(6-carboxyfluorescein) as a reporter dye at the 5′ end, 
and with TAMRA (6-carboxy-tetramethylrhodamine) 
as a quencher at the 3′ end. The final reaction was 
prepared with 12.5 μl of TaqMan Universal PCR master 
mix (2x) (Applied Biosystems®, Carlsbad, CA, USA), 
0.5 μl of each primer (10 μm), 0.5 μl of probe (5 
μm) and 6 μl of DEPC water. The reaction parameters 
were 2 minutes at 50°C and 10 minutes at 95°C, 
followed by 45 cycles (15 seconds at 95°C and 1 
minute at 60°C) by using an ABI 7300 PCR machine 
(Applied Biosystems®, Carlsbad, CA, USA). A plasmid 
pattern containing the large T antigen encoding region 
was used as a control to determine the number of 
copies per milliliter in the final reaction. The protocol 
employed has a high analytical sensitivity, that is, a 
detection limit of 1000 copies per milliliter (cp/mL) 
of blood.
Statistical analyses
To compare the presence of BKPyV in blood and 
saliva, the binomial proportion test was used. The 
variables “post-transplantation time after kidney 
transplantation” and “quantification of BKPyV in 
saliva and blood” did not present normal distribution 
(Kolmogorov-Smirnov, p<0,001). To verify the 
associations between salivary shedding BKPyV and 
post-transplant periods (in months), the Mann-
Whitney test was used. Spearman’s correlation was 
used to correlate the viral load in the saliva and blood 
of kidney transplant recipients. The resulting data 
were analyzed through the SPSS 17.0 software (SPSS 
Inc., Chicago, IL, USA). All tests were performed 
considering a significance level of 0.05.
Results
The mean age of the participants was 51.11±12.45 
years old, of whom 69 (54.8%) were male and 57 
(45.2%) were female. The mean post-transplantation 
time after kidney transplantation was 4.80+6.04 
months. BKPyV was quantified in 126 samples 
of saliva, with a mean of 4,761+11,105cp/mL 
(minimum= 63; maximum= 55,241, median= 
1,108), and in 52 blood samples, with a mean of 
93,604+364,227cp/mL (minimum= 80; maximum= 
1,459,398, median= 1,255), with the latter showing 
higher viral quantification. Only 16/52 (30.8%) 
participants presented BKPyV in blood, whereas 
59/126 (46.8%) excreted the virus in saliva (p=0.004) 
(Table 1). BKPyV shedding was found in patients 
with shorter post-transplantation period (3.86+5.25, 
p=0.103) (Table 2).
Fifty-two patients had paired samples of blood 
and saliva, and of these, only 11 (21.1%) had 
viremia and salivary shedding of BKPyV at the same 
time. Of these 52 individuals, the mean viral load 
in saliva was 1,079+2,916 cp/mL, and in blood it 
was 28,801+202,289. The viral load in saliva was 
correlated with the blood from these samples, and 
a weak correlation was observed between salivary 
shedding and blood viremia of BKPyV (Spearman’s 
correlation=0.193, p=0.170).
Discussion
BKPyV frequently reactivates in kidney transplant 
recipients due to immunosuppression. In urine, the 
BKPyV had a prevalence between 20.4% and 40%7,8,10-
13, with BKPyV viruria being detected in 4-5% of the 
kidney transplant recipients. PCR monitoring of BKPyV 
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BKPyV/SAMPLE n % Prevalence p
BLOOD
0.004*
Positive
Negative
16
36
30.8
69.2
30.8%
TOTAL1 52 100
SALIVA
Positive 59
67
46.8
53.2
46.8%
Negative
TOTAL 126 100
1Blood sample was collected from 52 patients
*Binomial proportion test, statistically significant results
Table 1- Detection and prevalence of BKPyV in blood and saliva 
samples
n % Post-transplantation 
time (months)
mean+SD
p
                              
BKPyV
in 
saliva
                              
Positive cases
0.1031
59 47.2 3.86+5.25
Negative cases
66 52.8 5.64+6.60
SD: standard deviation
¹Mann-Whitney
*One patient did not present any information on post-
transplantation time
Table 2- Relation between salivary shedding of BKPyV and post-
transplantation time
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with urine and blood samples is a rapid and beneficial 
method to prevent renal complications during long-
term care of kidney transplant recipients10,13,14.
However, oral fluids (e.g. saliva) have exhibited 
high prevalence of BKPyV, being also efficiently 
detected compared to urine and blood2. Furthermore, 
because saliva contains several biological markers 
which can also be detected in urine or blood tests, 
salivary fluids can be used to detect and monitor 
several pathologies with the same effectiveness1,15.
Although saliva is a potential material for diagnosis, 
it is also an important mean of contamination, which 
should be considered in kidney transplantation 
patients. Studies have shown that the prevalence of 
BKPyV in the saliva of these patients reaches 91.7%2, 
and it can be detected in the saliva of HIV-positive 
patients as well16. Oral fluids exhibit high prevalence 
of BKPyV and are equally efficient compared to urine 
and blood. When oral fluids are used in screening 
assays to detect polyomaviruses, the results are highly 
positive and are especially indicated for patients who 
are unable to urinate. This positivity in oral fluids 
occurs even when the patient has negative viremia, 
which indicates that saliva can be a means for early 
detection of BKPyV2,3.
In our study, 46.8% of the participants excreted the 
virus in their oral fluids, which is a lower percentage 
than that observed in literature. Diseases related to 
BKPyV may be associated with a specific immune 
deficiency as a result of the use of immunosuppressive 
drugs3,17.
The BKPyV was detected in oral fluids and 
infections, with its replication occurring in vitro in 
salivary gland cells, which justifies the BKPyV presence 
in the saliva18. These results support ours, especially 
when the presence of BKPyV in the saliva of kidney 
transplant recipients is significantly greater than in 
their blood.
In our study, the viral loads were higher in 
blood (93,604+364,227cp/mL) than in saliva 
(4,761+11,105cp/mL). Despite the presence of 
outliers, we believe there are strong indications that 
there are differences in quantification between saliva 
and blood, meaning that other studies should be 
conducted to confirm this hypothesis. An increased 
BKPyV replication occurs in immunosuppressed 
patients, resulting in the destruction of infected 
uroepithelial cells and increased inflammatory immune 
cells19. In renal transplant recipients, this destruction 
affects 5-8% of the kidney transplantations and is called 
BKPyV-associated nephropathy, which may result in 
graft-failure in the transplanted recipients18,20,21. In 
this sense, saliva could be useful to detect  viral 
levels predisposing to the development of this type of 
nephropathy. However, our results demonstrate that 
saliva is not reliable for this evaluation. Therefore, 
clinical and prospective studies are necessary to 
confirm this hypothesis.
A weak correlation between viral quantification in 
saliva and blood was observed in our study, showing 
two different and independent compartments of BKPyV 
replication. A recent study of polyomaviruses miRNA 
expression in saliva have shown that the oral cavity is a 
region of persistent infection of BKPyV, more frequently 
than plasma22. The fact that there was no concordance 
implies that replacing tests traditionally used for 
urine and blood screening is not recommended. 
Nevertheless, the use of oral fluids concomitant with 
other fluids enhances positive screening and is useful 
as a complementary test to detect polyomaviruses2. 
Although this study suggests that salivary shedding 
of BKPyV does not correlate with the active disease, 
one of its limitations was that we did not seek to 
associate the active disease with the salivary shedding 
of BKPyV. Thus, clinical studies with similar methods 
are suggested in kidney transplant patients with an 
active disease.
BKPyV shedding was found in patients with shorter 
post-transplantation period, but with no statistical 
significance. However, this result is consistent with the 
concept that infections in kidney transplant patients are 
more common in the first months after transplantation, 
when they have maximum immunosuppression5,23.
Mouth-washing with Listerine® has been used as 
an alternative method to collect saliva, being effective 
in viral preservation for analysis by real-time PCR. 
One study showed high frequency of detection and 
quantification of BKPyV with mouth-washing (23 of 
46 subjects), suggesting that such a method is also 
a good alternative for detecting and monitoring this 
virus2. We used the method of non-stimulated saliva 
collection, and the results were similar to those of the 
mouth-wash collection with Listerine® regarding the 
analysis through real-time PCR. These results suggest 
that the form of saliva collection has no influence on 
the laboratory analysis for BKPyV.
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Conclusion
In conclusion, BKPyV was more common in saliva 
than in blood, especially in recently transplanted 
patients. A weak correlation between salivary shedding 
and blood viremia was observed. Therefore, this study 
suggested that, although saliva excretes more BKPyV 
than blood, there is no reliable correlation between 
salivary shedding and blood viremia, showing two 
independent compartments of viral replication.
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